BRCR Global - Katy /ID# 267304

Katy, Texas 77450

1 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab — Recruiting now